$FPRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FIVE PRIME THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in FIVE PRIME THERAPEUTICS, INC.. Get notifications about new insider transactions in FIVE PRIME THERAPEUTICS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 11.97 | 58,000 | 694,260 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 18.69 | 45,000 | 841,050 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 19.25 | 75,000 | 1,443,750 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 11.14 | 25,521 | 284,304 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 10.77 | 3,209 | 34,561 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 7.26 | 12,063 | 87,577 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 5.54 | 9,142 | 50,647 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 8.49 | 4,747 | 40,302 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | D | 38.00 | 795 | 30,210 | 0 | 795 to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | D | 38.00 | 795 | 30,210 | 0 | 795 to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | D | 38.00 | 795 | 30,210 | 0 | 795 to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | D | 38.00 | 169,468 | 6,439,784 | 0 | 169.5 K to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 66,000 | 0 | 169,468 | 103.5 K to 169.5 K (+63.79 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 14,174 | 0 | 103,468 | 117.6 K to 103.5 K (-12.05 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 2,460 | 0 | 117,642 | 120.1 K to 117.6 K (-2.05 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 1,440 | 0 | 120,102 | 121.5 K to 120.1 K (-1.18 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 795 | 0 | 795 | 0 to 795 |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 795 | 0 | 795 | 0 to 795 |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 795 | 0 | 795 | 0 to 795 |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 2,385 | 0 | 121,542 | 123.9 K to 121.5 K (-1.92 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | D | 12.47 | 185,000 | 2,306,950 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Sell | D | 38.00 | 138,947 | 5,279,986 | 0 | 138.9 K to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Grant | A | 0.00 | 66,000 | 0 | 138,947 | 72.9 K to 138.9 K (+90.48 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Option Exercise | D | 5.78 | 20,000 | 115,600 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Option Exercise | D | 11.97 | 58,000 | 694,260 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Option Exercise | D | 18.69 | 50,000 | 934,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Option Exercise | D | 37.89 | 60,000 | 2,273,400 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Sell | D | 38.00 | 135,547 | 5,150,786 | 0 | 135.5 K to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Grant | A | 0.00 | 66,000 | 0 | 135,547 | 69.5 K to 135.5 K (+94.90 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Gift | G | 0.00 | 8,085 | 0 | 69,547 | 77.6 K to 69.5 K (-10.41 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | White David | See Remarks | Option Exercise | D | 5.25 | 25,000 | 131,250 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | White David | See Remarks | Option Exercise | D | 11.58 | 30,000 | 347,400 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | White David | See Remarks | Sell | D | 38.00 | 33,423 | 1,270,074 | 0 | 33.4 K to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 4.47 | 27,769 | 124,127 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 2.80 | 52,408 | 146,742 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 5.23 | 37,998 | 198,730 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 5.31 | 40,868 | 217,009 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 3.94 | 49,552 | 195,235 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 3.23 | 50,367 | 162,685 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 3.99 | 46,939 | 187,287 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 3.79 | 34,451 | 130,569 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 6.09 | 15,000 | 91,350 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 17.27 | 10,000 | 172,700 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 29.80 | 10,000 | 298,000 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 22.15 | 12,500 | 276,875 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 11.65 | 16,600 | 193,390 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Gift | G | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | D | 4.14 | 20,000 | 82,800 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | D | 6.09 | 15,000 | 91,350 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | D | 17.27 | 10,000 | 172,700 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | D | 29.80 | 10,000 | 298,000 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | D | 22.15 | 12,500 | 276,875 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Sell | D | 38.00 | 5,000 | 190,000 | 0 | 5 K to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 4.14 | 20,000 | 82,800 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 6.09 | 15,000 | 91,350 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 17.27 | 10,000 | 172,700 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 29.80 | 10,000 | 298,000 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 37.99 | 25,000 | 949,750 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | D | 4.14 | 20,000 | 82,800 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | D | 6.09 | 15,000 | 91,350 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | D | 17.27 | 10,000 | 172,700 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | D | 29.80 | 10,000 | 298,000 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | D | 22.15 | 12,500 | 276,875 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | D | 12.70 | 12,500 | 158,750 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Nicholson Garry A | Director | Option Exercise | D | 4.14 | 20,000 | 82,800 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Nicholson Garry A | Director | Option Exercise | D | 6.09 | 15,000 | 91,350 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Nicholson Garry A | Director | Option Exercise | D | 17.27 | 10,000 | 172,700 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Nicholson Garry A | Director | Option Exercise | D | 29.80 | 15,000 | 447,000 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | SCHAFER CAROL | Director | Option Exercise | D | 4.14 | 20,000 | 82,800 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | SCHAFER CAROL | Director | Option Exercise | D | 6.09 | 1,250 | 7,613 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | SCHAFER CAROL | Director | Option Exercise | D | 9.17 | 25,000 | 229,250 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Lyons-Williams Lori | Director | Option Exercise | D | 4.14 | 20,000 | 82,800 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Lyons-Williams Lori | Director | Option Exercise | D | 6.30 | 25,000 | 157,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Civik Thomas | President and CEO | Option Exercise | D | 2.72 | 480,000 | 1,305,600 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Civik Thomas | President and CEO | Sell | D | 38.00 | 68,971 | 2,620,898 | 0 | 69 K to 0 (-100.00 %) |
Apr 13 2021 | FPRX | FIVE PRIME THERAPE ... | Civik Thomas | President and CEO | Payment of Exercise | F | 37.94 | 11,088 | 420,679 | 68,971 | 80.1 K to 69 K (-13.85 %) |
Mar 02 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 22.23 | 1,158 | 25,742 | 123,433 | 124.6 K to 123.4 K (-0.93 %) |
Mar 02 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Payment of Exercise | F | 22.23 | 1,158 | 25,742 | 77,632 | 78.8 K to 77.6 K (-1.47 %) |
Mar 02 2021 | FPRX | FIVE PRIME THERAPE ... | White David | See Remarks | Payment of Exercise | F | 22.23 | 1,461 | 32,478 | 33,423 | 34.9 K to 33.4 K (-4.19 %) |
Feb 26 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 23.08 | 1,653 | 38,151 | 124,591 | 126.2 K to 124.6 K (-1.31 %) |
Feb 26 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 25.71 | 5,100 | 131,121 | 126,244 | 131.3 K to 126.2 K (-3.88 %) |
Feb 26 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Payment of Exercise | F | 23.08 | 1,653 | 38,151 | 78,790 | 80.4 K to 78.8 K (-2.05 %) |
Feb 26 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Payment of Exercise | F | 25.71 | 5,091 | 130,890 | 80,443 | 85.5 K to 80.4 K (-5.95 %) |
Feb 26 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Payment of Exercise | F | 25.71 | 5,110 | 131,378 | 72,947 | 78.1 K to 72.9 K (-6.55 %) |
Feb 26 2021 | FPRX | FIVE PRIME THERAPE ... | White David | See Remarks | Payment of Exercise | F | 25.71 | 1,155 | 29,695 | 34,884 | 36 K to 34.9 K (-3.20 %) |
Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | M | 0.00 | 22,000 | 0 | 0 | |
Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 16.14 | 11,583 | 186,950 | 126,427 | 138 K to 126.4 K (-8.39 %) |
Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Buy | M | 0.00 | 22,000 | 0 | 138,010 | 116 K to 138 K (+18.96 %) |
Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | M | 0.00 | 22,000 | 0 | 0 | |
Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Payment of Exercise | F | 16.14 | 11,504 | 185,675 | 78,057 | 89.6 K to 78.1 K (-12.84 %) |
Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Buy | M | 0.00 | 22,000 | 0 | 89,561 | 67.6 K to 89.6 K (+32.56 %) |
Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 22,000 | 0 | 0 | |
Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Payment of Exercise | F | 16.14 | 11,583 | 186,950 | 85,534 | 97.1 K to 85.5 K (-11.93 %) |
Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Buy | M | 0.00 | 22,000 | 0 | 97,117 | 75.1 K to 97.1 K (+29.29 %) |
Nov 30 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Payment of Exercise | F | 18.45 | 6,920 | 127,674 | 67,561 | 74.5 K to 67.6 K (-9.29 %) |
Nov 30 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Payment of Exercise | F | 18.45 | 6,920 | 127,674 | 67,561 | 74.5 K to 67.6 K (-9.29 %) |
Nov 13 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | Sell | S | 20.19 | 502,649 | 10,146,825 | 81,263 | 583.9 K to 81.3 K (-86.08 %) | |
Nov 13 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | Sell | S | 20.19 | 2,949,477 | 59,540,207 | 485,513 | 3.4 M to 485.5 K (-85.87 %) | |
Nov 13 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | Sell | S | 20.19 | 3,941,214 | 79,560,105 | 670,695 | 4.6 M to 670.7 K (-85.46 %) | |
Oct 08 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.04 | 25,107 | 126,414 | 566,223 | 541.1 K to 566.2 K (+4.64 %) |
Oct 08 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.04 | 162,352 | 817,442 | 3,281,151 | 3.1 M to 3.3 M (+5.21 %) |
Oct 08 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.04 | 157,782 | 794,432 | 4,336,875 | 4.2 M to 4.3 M (+3.78 %) |
Oct 02 2020 | FPRX | FIVE PRIME THERAPE ... | White David | See Remarks | Payment of Exercise | F | 4.70 | 6,916 | 32,505 | 36,039 | 43 K to 36 K (-16.10 %) |
Sep 24 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.80 | 32 | 122 | 541,116 | 541.1 K to 541.1 K (+0.01 %) |
Aug 24 2020 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Payment of Exercise | F | 4.69 | 827 | 3,879 | 64,156 | 65 K to 64.2 K (-1.27 %) |
Aug 24 2020 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Payment of Exercise | F | 4.69 | 827 | 3,879 | 64,156 | 65 K to 64.2 K (-1.27 %) |
May 18 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.10 | 4,476 | 18,352 | 541,084 | 536.6 K to 541.1 K (+0.83 %) |
May 18 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.10 | 39,810 | 163,221 | 3,118,799 | 3.1 M to 3.1 M (+1.29 %) |
May 18 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.10 | 249,301 | 1,022,134 | 4,179,093 | 3.9 M to 4.2 M (+6.34 %) |
May 18 2020 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | A | 4.14 | 20,000 | 82,800 | 20,000 | |
May 15 2020 | FPRX | FIVE PRIME THERAPE ... | Nicholson Garry A | Director | Option Exercise | A | 4.14 | 20,000 | 82,800 | 20,000 | |
May 15 2020 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | A | 4.14 | 20,000 | 82,800 | 20,000 | |
May 15 2020 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | A | 4.14 | 20,000 | 82,800 | 20,000 | |
May 15 2020 | FPRX | FIVE PRIME THERAPE ... | SCHAFER CAROL | Director | Option Exercise | A | 4.14 | 20,000 | 82,800 | 20,000 | |
May 15 2020 | FPRX | FIVE PRIME THERAPE ... | Lyons-Williams Lori | Director | Option Exercise | A | 4.14 | 20,000 | 82,800 | 20,000 | |
Apr 20 2020 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | A | 2.80 | 78,408 | 219,542 | 78,408 | |
Apr 20 2020 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | A | 2.80 | 78,408 | 219,542 | 78,408 | |
Apr 14 2020 | FPRX | FIVE PRIME THERAPE ... | Civik Thomas | President and CEO | Option Exercise | A | 2.72 | 480,000 | 1,305,600 | 480,000 | |
Apr 14 2020 | FPRX | FIVE PRIME THERAPE ... | Civik Thomas | President and CEO | Grant | A | 0.00 | 75,000 | 0 | 75,000 | 0 to 75 K |
Mar 23 2020 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Payment of Exercise | F | 2.30 | 827 | 1,902 | 64,983 | 65.8 K to 65 K (-1.26 %) |
Mar 20 2020 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Chief Executive Off ... | Option Exercise | A | 2.22 | 52,959 | 117,569 | 52,959 | |
Mar 11 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | A | 5.25 | 90,000 | 472,500 | 90,000 | |
Mar 11 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | A | 5.25 | 90,000 | 472,500 | 90,000 | |
Mar 11 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Grant | A | 0.00 | 15,000 | 0 | 63,389 | 48.4 K to 63.4 K (+31.00 %) |
Mar 11 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Grant | A | 0.00 | 15,000 | 0 | 48,389 | 33.4 K to 48.4 K (+44.92 %) |
Mar 03 2020 | FPRX | FIVE PRIME THERAPE ... | White David | See Remarks | Payment of Exercise | F | 3.83 | 2,045 | 7,832 | 42,955 | 45 K to 43 K (-4.54 %) |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | A | 5.25 | 90,000 | 472,500 | 90,000 | |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | A | 5.25 | 90,000 | 472,500 | 90,000 | |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 4.83 | 1,304 | 6,298 | 105,011 | 106.3 K to 105 K (-1.23 %) |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 4.87 | 1,863 | 9,073 | 106,315 | 108.2 K to 106.3 K (-1.72 %) |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 15,000 | 0 | 108,178 | 93.2 K to 108.2 K (+16.10 %) |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 15,000 | 0 | 93,178 | 78.2 K to 93.2 K (+19.19 %) |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Option Exercise | A | 5.25 | 90,000 | 472,500 | 90,000 | |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Option Exercise | A | 5.25 | 90,000 | 472,500 | 90,000 | |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Payment of Exercise | F | 4.83 | 1,281 | 6,187 | 65,810 | 67.1 K to 65.8 K (-1.91 %) |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Payment of Exercise | F | 4.87 | 1,862 | 9,068 | 67,091 | 69 K to 67.1 K (-2.70 %) |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Grant | A | 0.00 | 15,000 | 0 | 68,953 | 54 K to 69 K (+27.80 %) |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Grant | A | 0.00 | 15,000 | 0 | 53,953 | 39 K to 54 K (+38.51 %) |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | White David | See Remarks | Option Exercise | A | 5.25 | 25,000 | 131,250 | 25,000 | |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | White David | See Remarks | Grant | A | 0.00 | 10,000 | 0 | 45,000 | 35 K to 45 K (+28.57 %) |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | White David | See Remarks | Grant | A | 0.00 | 20,000 | 0 | 35,000 | 15 K to 35 K (+133.33 %) |
Feb 20 2020 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Chief Executive Off ... | Option Exercise | A | 5.23 | 37,998 | 198,730 | 37,998 | |
Feb 06 2020 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Payment of Exercise | F | 5.13 | 5,345 | 27,420 | 38,953 | 44.3 K to 39 K (-12.07 %) |
Feb 06 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 5.13 | 4,070 | 20,879 | 78,178 | 82.2 K to 78.2 K (-4.95 %) |